trimethylcolchicinic acid methyl ether has been researched along with Granulocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| PAOLINO, W; PIERRI, G; RESEGOTTI, L | 1 |
| Bateman, JR; Stolinsky, DC; Weiner, JM | 1 |
2 other study(ies) available for trimethylcolchicinic acid methyl ether and Granulocytic Leukemia
| Article | Year |
|---|---|
[Experimental study and first clinical application of a colchicine derivative with antiblastic action: methyl ester of trimethylcolchicinic acid (deacetylcolchicine)].
Topics: Antineoplastic Agents; Colchicine; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid | 1955 |
Rotational therapy with a colchicine analog in chronic granulocytic leukemia.
Topics: Adolescent; Adult; Aged; Bone Marrow; Busulfan; Colchicine; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Middle Aged | 1980 |